Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,459 | -3,322 | -1,784 | -7,853 | -5,453 |
| Other Working Capital | -647 | -473 | -721 | 371 | 323 |
| Other Operating Activity | 1,579 | 1,364 | 875 | 1,921 | 1,374 |
| Operating Cash Flow | $-3,527 | $-2,430 | $-1,630 | $-5,561 | $-3,756 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,469 | 349 | 3 | 3,609 | 3,130 |
| Other Financing Activity | -134 | -22 | 0 | 182 | 168 |
| Financing Cash Flow | $3,335 | $327 | $3 | $3,791 | $3,298 |
| Beginning Cash Position | 2,833 | 2,833 | 2,833 | 4,603 | 4,603 |
| End Cash Position | 2,642 | 731 | 1,206 | 2,833 | 4,145 |
| Net Cash Flow | $-191 | $-2,103 | $-1,627 | $-1,770 | $-458 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,527 | -2,430 | -1,630 | -5,561 | -3,756 |
| Free Cash Flow | -3,527 | -2,430 | -1,630 | -5,561 | -3,756 |